Literature DB >> 30055083

Substituting Sedentary Time With Physical Activity in Fibromyalgia and the Association With Quality of Life and Impact of the Disease: The al-Ándalus Project.

Blanca Gavilán-Carrera1, Víctor Segura-Jiménez2, Rania A Mekary3, Milkana Borges-Cosic1, Pedro Acosta-Manzano1, Fernando Estévez-López4, Inmaculada C Álvarez-Gallardo2, Rinie Geenen5, Manuel Delgado-Fernández1.   

Abstract

OBJECTIVE: There is an overall awareness of the detrimental health effects of sedentary time (ST) in fibromyalgia; however, data are limited on how replacement of ST with physical activity (PA) of different intensity may be related to health in this condition. The aim of this study was to examine how a substitution of ST with light PA (LPA) or moderate-to-vigorous PA (MVPA) is associated with quality of life and disease impact.
METHODS: This study comprised 407 women with fibromyalgia, mean ± SD age 51.4 ± 7.6 years. The time spent in ST and PA was measured with triaxial accelerometry. Quality of life and disease impact were assessed using the Short Form 36 (SF-36) health survey and the Revised Fibromyalgia Impact Questionnaire (FIQR), respectively. The substitution of ST with an equivalent time of LPA or MVPA and the associated outcomes were examined using isotemporal substitution analyses.
RESULTS: Substituting 30 minutes of ST with LPA in the isotemporal model was associated with better scores in bodily pain (B = 0.55), vitality (B = 0.74), and social functioning (B = 1.45) according to the SF-36, and better scores at all of the domains (function, overall impact, symptoms, and total impact) of the FIQR (B ranging from -0.95 to -0.27; all P < 0.05). When ST was replaced with MVPA, better physical role (B = 2.30) and social functioning (B = 4.11) of the SF-36 and function of the FIQR (B = -0.73) were observed (all P < 0.05).
CONCLUSION: In regression models, allocation of time of sedentary behavior to either LPA or MVPA was associated with better quality of life and lower disease impact in women with fibromyalgia.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Year:  2019        PMID: 30055083     DOI: 10.1002/acr.23717

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  5 in total

1.  Is type of work associated with physical activity and sedentary behaviour in women with fibromyalgia? A cross-sectional study from the al-Ándalus project.

Authors:  Maria José Girela-Rejón; Blanca Gavilán-Carrera; Esther Aparicio-Ortega; Milkana Borges-Cosic; Inmaculada C García-Rodríguez; Manuel Delgado-Fernández; Fernando Estévez-López
Journal:  BMJ Open       Date:  2020-04-28       Impact factor: 2.692

2.  Effect of Exergame Training and Detraining on Lower-Body Strength, Agility, and Cardiorespiratory Fitness in Women with Fibromyalgia: Single-Blinded Randomized Controlled Trial.

Authors:  Santos Villafaina; Yolanda Borrega-Mouquinho; Juan Pedro Fuentes-García; Daniel Collado-Mateo; Narcis Gusi
Journal:  Int J Environ Res Public Health       Date:  2019-12-24       Impact factor: 3.390

3.  Exploring the Relationship between Fibromyalgia-Related Fatigue, Physical Activity, and Quality of Life.

Authors:  Marcos C Alvarez; Maria Luiza L Albuquerque; Henrique P Neiva; Luis Cid; Filipe Rodrigues; Diogo S Teixeira; Rui Matos; Raúl Antunes; Verónica Morales-Sánchez; Diogo Monteiro
Journal:  Int J Environ Res Public Health       Date:  2022-04-17       Impact factor: 4.614

4.  Fibromyalgia: Associations Between Fat Infiltration, Physical Capacity, and Clinical Variables.

Authors:  Björn Gerdle; Olof Dahlqvist Leinhard; Eva Lund; Ann Bengtsson; Peter Lundberg; Bijar Ghafouri; Mikael Fredrik Forsgren
Journal:  J Pain Res       Date:  2022-08-27       Impact factor: 2.832

5.  Sedentary Time Accumulated in Bouts is Positively Associated with Disease Severity in Fibromyalgia: The Al-Ándalus Project.

Authors:  Víctor Segura-Jiménez; Blanca Gavilán-Carrera; Pedro Acosta-Manzano; Dane B Cook; Fernando Estévez-López; Manuel Delgado-Fernández
Journal:  J Clin Med       Date:  2020-03-09       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.